140 mg Q2W or 420 mg QM Placebo SC Q2W or QM LDLC 70 mg dL or nonHDLC 100 mg dL Followup Q 12 weeks Screening Lipid Stabilization and Placebo Runin High or moderate
Download Presentation The PPT/PDF document "Trial Design Evolocumab SC" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Copyright © 2024 DocSlides. All Rights Reserved